Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 10/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | RAD52 | P43351 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | RGS12 | O14924 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | APAF1 | O14727 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3698833 | 0.98 | PTPN1 (0.43) | PTPN1NPC1NPSR1MEN1KMT2A | |
| Fluoride Ion SCHEMBL9329663 | 0.97 | PTPN1 (0.42) | PTPN1NPC1NPSR1MEN1KMT2A | |
| Bromide SCHEMBL5143840 | 0.94 | NPSR1 (0.49) | NPC1NPSR1MEN1KMT2ARAD52 | |
| Bromide SCHEMBL17317392 | 0.94 | NPSR1 (0.49) | NPC1NPSR1MEN1KMT2ARAD52 | |
| SCHEMBL17317384 | 0.92 | KDM4E (0.50) | PTPN1NPC1NPSR1MEN1KMT2A | |
| SCHEMBL21049615 | 0.92 | KDM4E (0.50) | PTPN1NPC1NPSR1MEN1KMT2A | |
| SCHEMBL21049542 | 0.92 | KDM4E (0.50) | PTPN1NPC1NPSR1MEN1KMT2A | |
| SCHEMBL21049556 | 0.92 | KDM4E (0.50) | PTPN1NPC1NPSR1MEN1KMT2A | |
| Bromide SCHEMBL29479429 | 0.90 | BCHE (0.44) | NPC1RAB9ASMN1; SMN2BCHEACHE | |
| SCHEMBL3693226 | 0.90 | BCHE (0.41) | BCHEACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739742-A1 | LATENT CATALYST AND COATING COMPOSITIONS INCLUDING THE SAME | SWIMC LLC (US) | 2026-05-13 | — | — | EP | disclosed |
| WO-2025049313-A1 | LATENT CATALYST AND COATING COMPOSITIONS INCLUDING THE SAME | SWIMC LLC (US) | 2025-03-06 | — | — | WO | disclosed |
| US-7273953-B2 | Process for producing arylamine | FUJIFILM FINECHEMICALS CO., LTD. (JP) | 2007-09-25 | — | — | US | disclosed |
| US-20060069287-A1 | Process for producing arylamine | FUJIFILM FINECHEMICALS CO., LTD. (JP) | 2006-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060069287-A1 | Process for producing arylamine | TYR, AADAC, AOC2 | ACHE 1678/4885PTPN1 1428/4885NPC1 3410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.